You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AXID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Axid

A generic version of AXID was approved as nizatidine by EPIC PHARMA LLC on July 5th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AXID?
  • What are the global sales for AXID?
  • What is Average Wholesale Price for AXID?
Summary for AXID
US Patents:0
Applicants:3
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 82
Patent Applications: 5,012
DailyMed Link:AXID at DailyMed
Drug patent expirations by year for AXID
Paragraph IV (Patent) Challenges for AXID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AXID Oral Solution nizatidine 15 mg/mL 021494 1 2008-05-14

US Patents and Regulatory Information for AXID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings AXID AR nizatidine TABLET;ORAL 020555-001 May 9, 1996 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Braintree AXID nizatidine SOLUTION;ORAL 021494-001 May 25, 2004 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AXID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
Braintree AXID nizatidine SOLUTION;ORAL 021494-001 May 25, 2004 ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AXID

See the table below for patents covering AXID around the world.

Country Patent Number Title Estimated Expiration
Japan H021141 ⤷  Sign Up
Norway 155885 ⤷  Sign Up
Spain 8306135 ⤷  Sign Up
U.S.S.R. 1184443 "CПOCOБ ПOЛУЧEHИЯ ПPOИЗBOДHЫX TИAЗOЛA (EГO BAPИAHTЫ)" (METHOD OF PRODUCING THIAZOLE DERIVATIVES (VERSIONS)) ⤷  Sign Up
South Korea 850001795 ⤷  Sign Up
Poland 233295 ⤷  Sign Up
Denmark 164056 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.